New Delhi: India has got another vaccine in the fight against Corona. Today Johnson & Johnson’s single dose vaccine has been approved by the Drug Controller General of India for emergency use authorization. Union Health Minister Mansukh Mandaviya himself tweeted this information. With this, there have been five vaccines against corona in India.
The American company Johnson & Johnson has a single dose vaccine of Corona. Johnson & Johnson’s single-dose COVID vaccine was 85 percent effective against severe disease and demonstrated protection against hospitalization and death.
The vaccine is estimated to be stable for two years at -4°F (-20°C) and for a maximum of 4.5 months at a regular temperature of 2° to 8°C.
Till now, all the corona vaccines that India has got emergency use authorization are of double doses. It has previously been approved for emergency use authorization by Bharat Biotech’s Covaxin, Serum’s Covishield, Russia’s Sputnik-V, Moderna and all of these are double-dose vaccines.
There is a gap of 28 days between the two vaccine doses of Bharat Biotech, after the first dose of Serum Covishield, the second dose is given after 12 weeks. At the same time, there is a gap of 21 days between the two doses of Sputnik-V of Russia.
Johnson & Johnson is the second foreign vaccine of Corona which has got the approval of Emergency Use Authorization in India, it was earlier approved by Moderna’s vaccine. With the DCGI getting permission from Johnson & Johnson, there are now a total of five vaccines in the country.
According to the Union Health Ministry, a total of 50,10,09,609 vaccine doses have been given so far in India, out of which 39,00,41,560 first vaccine dose has been given while 11,09,68,049 both doses have been given.